| |
| |
|
| Insider
Information: |
Patel Snehal |
| Relationship: |
CEO and CFO, Director,... |
| City: |
Stafford |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,525,602 |
|
|
Indirect Shares
|
2,712,886 |
|
|
| Direct
Value |
$93,272,162 |
|
|
|
Indirect Value
|
$45,793,516 |
|
|
| Total
Shares |
8,238,488 |
|
|
| Total
Value |
$139,065,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Greenwich Lifesciences, Inc. |
GLSI |
CEO and CFO, Director,... |
2024-06-13 |
5,525,602 |
2022-06-24 |
2,712,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-01-06 |
4 |
B |
$15.18 |
$22,770 |
D/D |
1,500 |
2,731,386 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-01-20 |
4 |
B |
$17.37 |
$26,055 |
D/D |
1,500 |
2,732,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-12-09 |
4 |
B |
$13.11 |
$26,220 |
D/D |
2,000 |
2,724,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-20 |
4 |
B |
$17.68 |
$26,520 |
D/D |
1,500 |
5,345,277 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-10-14 |
4 |
B |
$9.75 |
$29,250 |
D/D |
3,000 |
2,719,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-11-03 |
4 |
B |
$9.11 |
$31,885 |
D/D |
3,500 |
5,307,677 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-09-19 |
4 |
B |
$8.95 |
$35,800 |
D/D |
4,000 |
5,296,177 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-01-27 |
4 |
B |
$19.35 |
$38,700 |
D/D |
2,000 |
2,734,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-05 |
4/A |
B |
$12.49 |
$43,715 |
D/D |
3,500 |
5,343,777 |
3.23 |
- |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-01-03 |
4 |
B |
$23.82 |
$48,831 |
D/D |
2,050 |
1,193,429 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-06-09 |
4 |
B |
$10.90 |
$49,050 |
D/D |
4,500 |
1,243,453 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-22 |
4 |
B |
$19.98 |
$49,950 |
D/D |
2,500 |
5,347,777 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2021-12-14 |
4 |
B |
$27.17 |
$49,992 |
D/D |
1,840 |
1,191,379 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-06-02 |
4 |
B |
$7.38 |
$49,992 |
D/D |
6,774 |
1,223,703 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-11-10 |
4 |
B |
$10.17 |
$50,838 |
D/D |
5,000 |
5,312,677 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-06-07 |
4 |
B |
$8.55 |
$51,300 |
D/D |
6,000 |
1,238,953 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-04 |
4 |
B |
$13.03 |
$53,423 |
D/D |
4,100 |
5,340,277 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-06-16 |
4 |
B |
$7.13 |
$57,040 |
D/D |
8,000 |
2,683,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-04-01 |
4 |
B |
$19.08 |
$57,240 |
D/D |
3,000 |
5,350,777 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-06-24 |
4 |
B |
$9.13 |
$59,025 |
I/I |
6,465 |
2,712,886 |
2.64 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-12-29 |
4 |
B |
$15.19 |
$60,760 |
D/D |
4,000 |
2,729,886 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-04-11 |
4 |
B |
$12.42 |
$62,100 |
D/D |
5,000 |
5,271,177 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • – |
2020-09-29 |
4 |
B |
$4.60 |
$76,710 |
D/D |
16,667 |
1,184,839 |
2.81 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2022-06-03 |
4 |
B |
$8.35 |
$77,238 |
D/D |
9,250 |
1,232,953 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-04-19 |
4 |
B |
$11.10 |
$77,700 |
D/D |
7,000 |
5,286,177 |
3.23 |
% |
|
63 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
